The Global HIV Vaccine Enterprise
is an alliance of independent organizations around the world dedicated to accelerating the development of a preventive HIV vaccine by:
- Shared scientific plan: Implementing a strategic plan for HIV vaccine research that spans vaccine discovery, product development and manufacturing, and clinical trials
- Increased resources: Mobilizing significant new funding to achieve the scientific plan
- Greater collaboration: Promoting more efficient, faster ways for researchers to share successes and failures and avoid duplication of efforts
The Enterprise Approach
Enterprise Statement on New U.K. Support for HIV Prevention Technologies – November 14, 2008
Last week the U.K. Department for International Development (DFID) announced a £220 million fund to support research for
the development of new HIV prevention technologies including a safe and effective preventive HIV vaccine. Please see the below
link for a statement from Enterprise Executive Director Dr. Alan Bernstein commending the U.K. Government for its continued
commitment to HIV prevention research.
Enterprise DFID Statement
Summary Statement on AIDS Vaccine 2008 and Enterprise Press Coverage – November 13, 2008
The Global HIV Vaccine Enterprise and the local hosts of AIDS Vaccine 2008 convened more than 900 of the world’s
leading vaccine scientists, advocates, and policymakers in Cape Town, South Africa, from October 13-16, at the
eighth annual AIDS Vaccine conference. Please see the below link for a statement on the conference from Enterprise
Executive Director Dr. Alan Bernstein and Conference Chair Dr. Lynn Morris. In addition, please see the linked articles
for conference press coverage.
Summary Statement
Cape Times Article
LA Times Article
Mail & Guardian Article
Save the Date! AIDS Vaccine 2009, October 19-22 in Paris, France - October 28, 2008
The Global HIV Vaccine Enterprise and the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) are pleased to announce that the AIDS Vaccine 2009 conference will take place October 19-22 in Paris, France at the Marriott Rive Gauche Hotel and Conference Center. Please see the below link for a save the date flyer with more information and important dates.
Save the Date Flyer
Enterprise Statement on the Opening of the AIDS Vaccine 2008 Conference – October 13, 2008
The AIDS Vaccine 2008 Conference opened today in Cape Town, South Africa. Please see the below link for the Enterprise Executive Director Alan Bernstein’s statement on the opening of the conference.
Statement on Opening Conference
Global HIV Vaccine Enterprise Congratulates Drs. Francoise Barre-Sinoussi and Luc Montagnier on Receiving the 2008 Nobel Prize in Medicine – October 7, 2008
The Nobel Committee of the Karolinska Institute announced yesterday that Drs. Francoise Barre-Sinoussi and Luc Montagnier will share half of the 2008 Nobel Prize in Physiology or Medicine for their contributions to the identification of HIV, the virus that causes AIDS. Please see the below link for a statement from Enterprise Executive Director Alan Bernstein congratulating them on this achievement.
Statement by Dr. Alan Bernstein
More News from the Enterprise
Scientific Strategic Plan
The Enterprise's scientific strategic plan for accelerating HIV vaccine research was published in the February 2005 issue of Public Library of Science (PLoS) — Medicine